Regeneron Pharmaceuticals, Inc. (REGN)
702.36
-6.85
(-0.97%)
USD |
NASDAQ |
May 05, 16:00
697.90
-4.46
(-0.64%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap : 73.63B for May 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.95B |
| Eli Lilly & Co. | 881.18B |
| Merck & Co., Inc. | 279.49B |
| Pfizer Inc. | 150.37B |
| AbbVie, Inc. | 364.37B |
Market Cap Related Metrics
| PE Ratio | 17.11 |
| PS Ratio | 5.072 |
| PEG Ratio | 3.827 |
| Price to Book Value | 2.343 |
| Price to Free Cash Flow | 19.96 |
| Price | 702.36 |
| Earnings Yield | 5.84% |
| PEGY Ratio | 3.438 |
| Operating PE Ratio | 19.69 |
| Normalized PE Ratio | 16.93 |